STSA — Satsuma Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $36.47m
- -$4.90m
Annual cashflow statement for Satsuma Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.35 | -28.2 | -47.6 | -51.2 | -70.1 |
| Depreciation | |||||
| Non-Cash Items | 0.013 | 0.755 | 4.2 | 6.68 | 17.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.295 | -2.36 | 0.794 | 1.1 | 0.367 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.98 | -29.6 | -42.3 | -43 | -51.5 |
| Capital Expenditures | -0.402 | -0.551 | -5.17 | -2.03 | -0.472 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -95.3 | 63.2 | -48.7 | 43.8 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.402 | -95.9 | 58 | -50.8 | 43.4 |
| Financing Cash Flow Items | — | — | -0.235 | 75.2 | 9.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.9 | 143 | -2.1 | 73.3 | 8.74 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.55 | 17.6 | 13.6 | -20.5 | 0.594 |